Arteriosclerosis, Thrombosis and Vascular Biology-Peripheral Vascular Disease 2015 Scientific Sessions
The meeting includes diverse disciplines within the arteriosclerosis, thrombosis, vascular biology, functional genomics, peripheral vascular disease, and vascular surgery research communities that allow investigators to explore areas of cross-disciplinary interests.
View Activity Information

Arteriosclerosis, Thrombosis and Vascular Biology-Peripheral Vascular Disease 2015 Scientific Sessions

 

Participation and Successful Completion

Successful completion of this CE activity includes the following: (1) Register and view the course online. (2) Complete the evaluation survey (3) Print your CME/CE Certificate from your own printer.  There is no fee for CME/CE credits for this activity.  The link to the CME/CE “Professional Education Center” website is learn.heart.org.

 

Hardware/Software Requirements

Internet Explorer 7 or greater

Firefox (Latest Version)

Google Chrome

Windows 7 or above

Safari (Latest Version)

Adobe Acrobat Reader

Internet Explorer is not supported on the Macintosh.

Mac OS 10.4

 

Workshop Location

Hilton San Francisco Union Square Hotel

333 O'Farrell Street

San Francisco, California 94102

 

Cost to Attend

There is no fee for CME/CE credits for this activity.

 

Target Audience

Physicians and Scientists -

Arteriosclerosis, Biochemistry, Biological Sciences, Biophysics, Cardiology, Cell Biology, Chemistry, Clinical Pharmacology, Diabetes, Metabolism, Endocrinology, Epidemiology, Genetics, Hematology, Hypertension, Internal Medicine, Molecular Biology, Nutrition, Pathology, Physiology, Vascular Surgery, General Surgery, Thrombosis, Vascular Medicine

 

Description

This 2½-day meeting is sponsored by the Council on Arteriosclerosis, Thrombosis and Vascular Biology and the Council on Peripheral Vascular Disease, in cooperation with the Council on Functional Genomics and Translational Biology and the Society for Vascular Surgery.

The meeting includes diverse disciplines within the arteriosclerosis, thrombosis, vascular biology, functional genomics, peripheral vascular disease, and vascular surgery research communities that allow investigators to explore areas of cross-disciplinary interests.

Special lectures, discussions and oral and poster presentations are planned. The meeting format is designed to provide opportunities for intense interaction among participants during sessions and breaks. We expect a broad representation from many disciplines and encourage young scientists to attend.

 

Learning Objectives 

At the completion of this course, the learner will be able to:

  1. Review recent advances in knowledge regarding the role of LDL-C and non-HDL-C in atherosclerosis, the 2013 ACC/AHA cholesterol guidelines, and the clinical implications to improving cardiovascular outcomes.
  1. Describe recent findings regarding the role and mechanism of action of TGRL in cardiovascular disease, approaches to assess TGRL proteins, the results of large genetic studies implicating TGRL in atherosclerosis, and the clinical relevance of this research.
  1. Identify current controversies in the contribution of HDL-C to atherosclerosis and their clinical implications.
  1. Evaluate recent research related to HDL-C mechanisms in CVD, including HDL function assessment and implications for the prevention and treatment of atherosclerosis.
  1. Review the latest research into the signaling and genetic pathways involved in vascular dysfunction and for new therapeutic options and management.
  1. Describe current efforts to reverse vascular damage through medical therapy and vascular regeneration.
  1. Identify novel genomic and circulating biomarkers that could be used to assess CVD risk and discuss the strengths and weaknesses of each.
  1. Describe the biology of cardio-metabolic pathways and risk factors as they relate to the development and progression of cardiovascular disease and diabetes, and potential options for management.
  1. Review novel mechanisms and emerging antithrombotics that reduce atherothrombosis without increasing the bleeding risk.

 

 

Course Agenda

The agenda can be viewed separately in the activity.

 

Faculty

Sonia Anand, MD, PhD, FRCPC

McMaster University

Hamilton, Canada

 

Jeffrey Berger, MD, MS

New York University School of Medicine

New York, NY

 

Alan Daugherty, PhD, DSc, FAHA

University Of Kentucky

Lexington, KY

 

Xiaoping Du, MD, PhD

University of Illinois at Chicago

Chicago, IL

 

Jennifer Doudna

UC Berkeley

Berkeley, CA

 

Jane Freedman, MD

University of Massachusetts Medical Center

Worcester, MA

 

Bruce Furie, MD

Harvard Medical School

Boston, MA

 

Zorina Galis, PhD

NIH/NHLBI, Chief, Vascular Biology and Hypertension Branch

Bethesda, MD

 

Christopher Glass, MD, PhD, FAHA

University of California, San Diego

La Jolla, CA

 

Jay Horton, MD

UT Southwestern Medical School

Dallas, TX

 

Paul Kubes, PhD

University of Calgary

Calgary, AB

 

Jonathan Lindner, MD

Oregon Health & Science University

Portland, OR

 

Esther Lutgens, MD, PhD

University of Amsterdam

Amsterdam, Netherlands

 

Kathleen Martin, PhD

Yale University School of Medicine, Section of Cardiovascular Medicine

New Haven, CT

 

Kiran Musunuru, MD, PhD

Harvard University

Cambridge, MA

 

Christopher Overall, PhD

University of British Columbia

Vancouver, BC

 

Len Pennacchio, PhD

Lawrence Berkeley National Laboratory, Department of Genome Sciences

Berkeley, CA

 

Jorge Plutzky, MD

Brigham and Women's Hospital

Boston, MA

 

Katey Rayner, PhD

University of Ottawa Heart Institute

Ottawa, Canada

 

Muredach Reilly, MD, FAHA

University of Pennsylvania

Philadelphia, PA

 

Robert Ryan, PhD

Children's Hospital Oakland Research Institute

Oakland, CA

 

Lakshmi Santhanam, PhD

Johns Hopkins University

Baltimore, MD

 

Ann Marie Schmidt, MD

NYU Langone Medical Center

New York, NY

 

Hiroaki Shimokawa, MD, PhD

Tohoku University

Sendai, Japan

 

Janet Sparks, PhD, FAHA

University of Rochester Medical Center

Rochester, NY

 

Ahmed Tawakol, MD

Massachusetts General Hospital

Boston, MA

 

Roger Tsien, PhD

University of California at San Diego

San Diego, CA

 

Accreditation Statements:

 

Continuing Medical Education Accreditation - Physicians

The American Heart Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

The American Heart Association designates this live activity for a maximum of 21.25 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All persons who develop and/or control educational content in CME/CE activities sponsored by the American Heart Association will disclose to the audience all financial relationships with any commercial supporters of this activity as well as with other commercial interests whose lines of business are related to the CME/CE-certified content of this activity.  In addition, presenters will disclose unlabeled/unapproved uses of drugs or devices discussed in their presentations.  Such disclosures will be made in writing in course presentation materials.

 

Continuing Medical Education Accreditation – Physician Assistants

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 21.25 hours of Category I credit for completing this program.

 

Continuing Education Accreditation – Nurse Practitioners

American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 CreditTM from organizations accredited by the ACCME.

** ACCME credit must be claimed within 6 months of attendance. CME/CE credit will no longer be available to claim for this November 9, 2015.

 

Steps for Successful Completion

To successfully complete this activity, learners must fully participate in the sessions.  In addition, learners must provide feedback that will be used for evaluative and outcomes measurement purposes.  Learners will check-in onsite for attendance verification purposes and will be required to provide evaluative feedback before CME/CE credit can be claimed.

 

Disclosures

Faculty Member

Employment

Research Grant

Consultant/
Advisory Board

Stock Shareholder (directly purchased)

Honoraria

Other

Speaker’s Bureau

Sonia Anand

McMaster University

None

None

None

None

None

Jeffrey Berger

New York University School of Medicine

None

None

None

None

None

Alan Daugherty

University Of Kentucky

None

None

None

None

None

Xiaoping Du

University of Illinois at Chicago

None

None

PFE Pharmaceutical, DMT Inc, MRK, ABT

None

None

Jennifer Doudna

UC Berkeley

None

None

None

None

None

Jane Freedman

University of Massachusetts Medical Center

None

None

None

None

None

Bruce Furie

Harvard Medical School

None

None

None

None

None

Zorina Galis

NIH/NHLBI, Chief, Vascular Biology and Hypertension Branch

None

None

None

None

None

Christopher Glass

University of California, San Diego

None

None

None

None

None

Jay Horton

UT Southwestern Medical School

None

Merck, Pfizer, Sanofi-Aventis, Regeneron, Alnylam, Aegerion, Catabasis, Amgen, Novartis

None

None

None

Paul Kubes

University of Calgary

None

None

None

None

None

Jonathan Lindner

Oregon Health & Science University

GE Healthcare

None

None

None

None

Esther Lutgens

University of Amsterdam

None

None

None

None

None

Kathleen Martin

Yale University School of Medicine

NHLBI

None

None

None

None

Kiran Musunuru

Harvard University

None

None

None

None

None

Christopher Overall

University of British Columbia

None

None

None

None

None

Len Pennacchio

Lawrence Berkeley National Laboratory

None

None

None

None

None

Jorge Plutzky

Brigham and Women's Hospital

None

None

None

None

None

Katey Rayner

University of Ottawa Heart Institute

None

None

None

None

None

Muredach Reilly

University of Pennsylvania

None

None

None

None

None

Robert Ryan

Children's Hospital Oakland Research Institute

None

None

None

None

None

Lakshmi Santhanam

Johns Hopkins University

None

None

None

None

None

Ann Marie Schmidt

NYU Langone Medical Center

None

None

None

None

None

Hiroaki Shimokawa

Tohoku University

None

Asahi Kasei Pharma, Storz Medical

None

None

None

Janet Sparks

University of Rochester Medical Center

None

None

None

None

None

Ahmed Tawakol

Massachusetts General Hospital

Takeda Pharmaceuticals, Genetech/Roche

Significant; Amgen, Actelion

None

None

None

Roger Tsien

University of California at San Diego

None

Avelas Biosciences

Avelas Biosciences

None

None

Josh

Beckman

Brigman and Women's Hospital

None

Novartis

Janacare, EMX, Salmon Run Capital

None

VIVA Physicians

Michael

Conte

UCSF Heart and Vascular Center

None

None

Talecris Biotherapeutics; Data Safety Monitoring Board for Clinical Trial, Vascular Cures; Member, Board of Trustees Cook Medical; Scientific Advisor

None

None

Edward

Conway

University of British Columbia

Biogen-Idec; Bayer Pharmaceutical; Morphotek

None

None

None

None

Mark

Crowther

McMaster University

None

None

None

None

None

John

Curci

Vanderbilt University Medical Center

None

None

None

None

None

Alan

Daugherty

University of Kentucky

None

None

None

None

None

Sean

Davidson

University of Cincinnati

None

None

None

None

None

Robert

Flaumenhaft

Harvard Medical School

None

None

None

None

None

Jennifer

Hall

University of Minnesota

None

None

None

None

None

David

Harrison

Vanderbilt University School of Medicine

None

None

None

None

None

Catherine

Hedrick

La Jolla Institute for Allergy and Immunology

None

None

None

None

None

Ken

Hirata

Kobe University

None

None

None

None

None

Joseph

Italiano

Brigham and Women's Hospital

None

None

None

None

None

Iftikhar

Kullo

Mayo Clinic

None

None

None

None

None

Steven

Lentz

University of Iowa

Novo Nordisk

Celgene

Lars

Maegdefessel

Karolinska Institute

None

None

None

None

None

Ziad

Mallat

University of Cambridge

None

None

None

None

None

Jordan

Miller

Mayo Clinic

None

None

None

None

None

Sanjay

Misra

Mayo Clinic

NIH

None

None

None

J & J, DSMB: Flextent

Kathryn

Moore

NYU

None

None

None

None

None

Phil

Tsao

Stanford University

None

None

None

None

None

Greg

Piazza

Harvard Medical School

BMS; Daiichi Sankyo; Janssen; EKOS, a BTG International Group Company; Thrombosis Research Institute; NHLBI

None

None

None

None

Geoff

Pickering

Robarts Research Institute

None

None

None

None

None

Hong

Wang

Temple University School of Medicine

None

None

None

None

None

Kerry Anne

Rye

University of New South Wales

None

None

None

None

None

Daisy

Sahoo

Medical College of Wisconsin

None

None

None

None

None

Jonathan

Smith

Lerner Research Institute, Cleveland Clinic

NIH

Cleveland Heart Lab, Esperion Therapeutics

None

None

None

Karol

Watson

UCLA Center for Cholesterol and Lipid Management

NHLBI, NIDDK

Aegerion

None

None

Merck & Co, Clinical Trials Adjudication Committee, Partnership for Prevention, Council Member

Andrew

Weyrich

University of Utah School of Medicine

None

None

None

None

None

Alisa

Wolberg

University of North Carolina School of Medicine

None

None

None

None

None

 

This table represents the relationships of this educational activity’s faculty members that may be perceived as actual or reasonable perceived conflicts of interest as reported on the Disclosure Questionnaire which all AHA volunteers are required to complete and submit. The focus is on relevant financial relationships with commercial interests in the 12-month period preceding the time that the individual is being asked to assume a role controlling content.


Medium

This activity is a live or a virtual link activity depending on the location.

 

Contact Information

To contact the American Heart Association for any questions, please call our customer support center at 888-242-2453.

 

Policy on Privacy and Confidentiality:

Please see the privacy link at the bottom of the Professional Education Center

 

Copyright Information
Please see the link at the bottom of the Professional Education Center

 

Commerical Support

No commercial support was obtained. 

Type:  Live Activity
FREE
Activity Price
39 Registered Users
Live Meeting Information
Start: Thursday, May 7, 2015 - 7:00 AM
End:
Saturday, May 9, 2015 - 12:00 PM

Location: Hilton San Francisco Union Square Hotel
333 O'Farrell Street
San Francisco, CA 94102
US

Credits
21.25 Credits> Accreditation Council for Continuing Medical Education> AMA PRA Category 1 Credit

0 Credits> American Heart Association> AHA

21.25 Credits> Accreditation Council for Continuing Medical Education> Attendance Credit